Abstract
Introduction: Intravenous immunoglobulin (IVIG) is one of the drugs used to treat COVID-19. The aim of this study was to evaluate the role of IVIG in the treatment of COVID-19 in hospitalized patients. Materials and methods: The patients received IVIG before being intubated. The patients’ symptoms, disease severity, clinical features, and chest computed tomography findings were compared between before and after the treatment. Results: Out of 62 patients who received IVIG, 35 patients (56.5%) were male, and 27 patients (43.5%) were female. Overall, 13 (21%) patients died, and 49 (79%) recovered and were discharged from the hospital. Conclusion: IVIG can be used as an effective drug to save patients’ lives before they enter the intubation phase.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
